Impact of blood parameters and normal tissue dose on treatment outcome in esophageal cancer patients undergoing neoadjuvant radiochemotherapy

Despite technological advances, normal tissue sparing in photon beam irradiation is still challenging. Since in esophageal cancer this may inflict damage on the lungs, heart and bone marrow, possibly impacting on outcome, the aim of this study was to investigate the association of normal tissue dose...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bütof, Rebecca (VerfasserIn) , Häberlein, Laura (VerfasserIn) , Jentsch, Christina (VerfasserIn) , Kotzerke, Jörg (VerfasserIn) , Lohaus, Fabian (VerfasserIn) , Makocki, Sebastian (VerfasserIn) , Valentini, Chiara (VerfasserIn) , Weitz, Jürgen (VerfasserIn) , Löck, Steffen (VerfasserIn) , Troost, Esther Gera Cornelia (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 July 2022
In: Cancers
Year: 2022, Jahrgang: 14, Heft: 14, Pages: 1-12
ISSN:2072-6694
DOI:10.3390/cancers14143504
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers14143504
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/14/14/3504
Volltext
Verfasserangaben:Rebecca Bütof, Laura Häberlein, Christina Jentsch, Jörg Kotzerke, Fabian Lohaus, Sebastian Makocki, Chiara Valentini, Jürgen Weitz, Steffen Löck and Esther G.C. Troost

MARC

LEADER 00000caa a2200000 c 4500
001 1815778644
003 DE-627
005 20230118150854.0
007 cr uuu---uuuuu
008 220905s2022 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers14143504  |2 doi 
035 |a (DE-627)1815778644 
035 |a (DE-599)KXP1815778644 
035 |a (OCoLC)1361696802 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bütof, Rebecca  |d 1986-  |e VerfasserIn  |0 (DE-588)1017287856  |0 (DE-627)690301081  |0 (DE-576)350777977  |4 aut 
245 1 0 |a Impact of blood parameters and normal tissue dose on treatment outcome in esophageal cancer patients undergoing neoadjuvant radiochemotherapy  |c Rebecca Bütof, Laura Häberlein, Christina Jentsch, Jörg Kotzerke, Fabian Lohaus, Sebastian Makocki, Chiara Valentini, Jürgen Weitz, Steffen Löck and Esther G.C. Troost 
264 1 |c 19 July 2022 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.09.2022 
520 |a Despite technological advances, normal tissue sparing in photon beam irradiation is still challenging. Since in esophageal cancer this may inflict damage on the lungs, heart and bone marrow, possibly impacting on outcome, the aim of this study was to investigate the association of normal tissue dose and blood parameters on the survival of patients having undergone neoadjuvant radiochemotherapy (RCTx) followed by surgery. This retrospective study included 125 patients irradiated to 40-41.4 Gy with photons or protons combined with concurrent chemotherapy. On initial and restaging 18F-FDG-PET/CT, the lungs and heart were contoured as organs at risk for which standardized uptake values (SUV) were evaluated. The mean radiation dose (Dmean) to the lungs and heart, the volume of the lungs receiving at least 20 Gy (V20Gy_lung) and various pre- and per-treatment blood parameters were included in the Cox regression analyses. Results: The median follow-up time was 19.8 months and median overall survival 37 months (95% confidence interval: 16-58.9 months). In multivariate analysis, higher radiation doses to the lungs and heart were statistically significantly associated with decreased overall survival (Dmean_lung: p < 0.001; V20Gy_lung: p < 0.002; Dmean_heart: p = 0.005). Neither the 18F-FDG-PET nor blood parameters were predictive for overall survival. In patients with locally advanced esophageal cancer treated with RCTx, the radiation dose to the heart and lungs was significantly associated with overall survival. 
650 4 |a blood parameters 
650 4 |a esophageal cancer 
650 4 |a neoadjuvant 
650 4 |a normal tissue dose 
650 4 |a outcome 
650 4 |a PET 
650 4 |a radiochemotherapy 
700 1 |a Häberlein, Laura  |e VerfasserIn  |4 aut 
700 1 |a Jentsch, Christina  |e VerfasserIn  |4 aut 
700 1 |a Kotzerke, Jörg  |e VerfasserIn  |4 aut 
700 1 |a Lohaus, Fabian  |e VerfasserIn  |0 (DE-588)1182057152  |0 (DE-627)1662558686  |4 aut 
700 1 |a Makocki, Sebastian  |e VerfasserIn  |4 aut 
700 1 |a Valentini, Chiara  |d 1983-  |e VerfasserIn  |0 (DE-588)1268053619  |0 (DE-627)1816652245  |4 aut 
700 1 |a Weitz, Jürgen  |e VerfasserIn  |0 (DE-588)1022345974  |0 (DE-627)716954451  |0 (DE-576)171632176  |4 aut 
700 1 |a Löck, Steffen  |d 1982-  |e VerfasserIn  |0 (DE-588)141342943  |0 (DE-627)626890551  |0 (DE-576)323124631  |4 aut 
700 1 |a Troost, Esther Gera Cornelia  |d 1978-  |e VerfasserIn  |0 (DE-588)135713250  |0 (DE-627)570561221  |0 (DE-576)300603169  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 14(2022), 14, Artikel-ID 3504, Seite 1-12  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Impact of blood parameters and normal tissue dose on treatment outcome in esophageal cancer patients undergoing neoadjuvant radiochemotherapy 
773 1 8 |g volume:14  |g year:2022  |g number:14  |g elocationid:3504  |g pages:1-12  |g extent:12  |a Impact of blood parameters and normal tissue dose on treatment outcome in esophageal cancer patients undergoing neoadjuvant radiochemotherapy 
856 4 0 |u https://doi.org/10.3390/cancers14143504  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/14/14/3504  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20220905 
993 |a Article 
994 |a 2022 
998 |g 135713250  |a Troost, Esther Gera Cornelia  |m 135713250:Troost, Esther Gera Cornelia  |p 10  |y j 
999 |a KXP-PPN1815778644  |e 4184661998 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Rebecca Bütof, Laura Häberlein, Christina Jentsch, Jörg Kotzerke, Fabian Lohaus, Sebastian Makocki, Chiara Valentini, Jürgen Weitz, Steffen Löck and Esther G.C. Troost"]},"person":[{"display":"Bütof, Rebecca","given":"Rebecca","role":"aut","family":"Bütof"},{"display":"Häberlein, Laura","given":"Laura","role":"aut","family":"Häberlein"},{"family":"Jentsch","display":"Jentsch, Christina","role":"aut","given":"Christina"},{"role":"aut","given":"Jörg","display":"Kotzerke, Jörg","family":"Kotzerke"},{"family":"Lohaus","role":"aut","given":"Fabian","display":"Lohaus, Fabian"},{"given":"Sebastian","role":"aut","display":"Makocki, Sebastian","family":"Makocki"},{"family":"Valentini","role":"aut","given":"Chiara","display":"Valentini, Chiara"},{"given":"Jürgen","role":"aut","display":"Weitz, Jürgen","family":"Weitz"},{"display":"Löck, Steffen","role":"aut","given":"Steffen","family":"Löck"},{"family":"Troost","display":"Troost, Esther Gera Cornelia","given":"Esther Gera Cornelia","role":"aut"}],"origin":[{"dateIssuedDisp":"19 July 2022","dateIssuedKey":"2022"}],"recId":"1815778644","type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"pubHistory":["1.2009 -"],"title":[{"title":"Cancers","title_sort":"Cancers"}],"part":{"extent":"12","pages":"1-12","issue":"14","year":"2022","text":"14(2022), 14, Artikel-ID 3504, Seite 1-12","volume":"14"},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"614095670","origin":[{"publisher":"MDPI","dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisherPlace":"Basel"}],"disp":"Impact of blood parameters and normal tissue dose on treatment outcome in esophageal cancer patients undergoing neoadjuvant radiochemotherapyCancers","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2527080-1"],"issn":["2072-6694"],"eki":["614095670"]},"note":["Gesehen am 27.05.2020"],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]}}],"note":["Gesehen am 05.09.2022"],"physDesc":[{"extent":"12 S."}],"id":{"doi":["10.3390/cancers14143504"],"eki":["1815778644"]},"language":["eng"],"title":[{"title_sort":"Impact of blood parameters and normal tissue dose on treatment outcome in esophageal cancer patients undergoing neoadjuvant radiochemotherapy","title":"Impact of blood parameters and normal tissue dose on treatment outcome in esophageal cancer patients undergoing neoadjuvant radiochemotherapy"}]} 
SRT |a BUETOFREBEIMPACTOFBL1920